Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (431-440 of 1,376) with videos related to

Pageof 138
Sort By:
Drug Development Research|August 26, 2015
Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary FibrosisRichard Seonghun Nho
Drug Development Research|August 19, 2015
MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in CancerSriganesh B Sharma, John Michael Ruppert
Drug Development Research|August 20, 2015
Validated MicroRNA Target Databases: An EvaluationYun Ji Diana Lee, Veronica Kim, Dillon C Muth, et al.
Drug Development Research|November 11, 2014
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitisAlberto Cauli, Matteo Piga, Grazia Dessole, et al.
Drug Development Research|November 11, 2014
Management of patients with psoriasis treated with biological drugs needing a surgical treatmentAntonella Fabiano, Clara De Simone, Paolo Gisondi, et al.
Drug Development Research|November 11, 2014
Assays and strategies for immunogenicity assessment of biological agentsFrancesca Nencini, Sara Pratesi, Giulia Petroni, et al.
Drug Development Research|November 11, 2014
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature reviewMaria Sole Chimenti, Francesca Romana Spinelli, Alessandro Giunta, et al.
Drug Development Research|November 11, 2014
Pharmacogenetics and future therapeutic scenarios: what affects the prediction of response to treatment with etanercept?Giuseppe Murdaca, Rossella Gulli, Francesca Spanò, et al.
Drug Development Research|November 11, 2014
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical responseFabio Cacciapaglia, Maria Grazia Anelli, Angela Rinaldi, et al.
Drug Development Research|November 11, 2014
Cardiovascular risk in psoriatic patients detected by heart rate variability (HRV) analysisIlaria Proietti, Gianfranco Raimondi, Nevena Skroza, et al.
Pageof 138

Showing results (431-440 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|August 26, 2015
Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary FibrosisRichard Seonghun Nho
Drug Development Research|August 19, 2015
MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in CancerSriganesh B Sharma, John Michael Ruppert
Drug Development Research|August 20, 2015
Validated MicroRNA Target Databases: An EvaluationYun Ji Diana Lee, Veronica Kim, Dillon C Muth, et al.
Drug Development Research|November 11, 2014
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitisAlberto Cauli, Matteo Piga, Grazia Dessole, et al.
Drug Development Research|November 11, 2014
Management of patients with psoriasis treated with biological drugs needing a surgical treatmentAntonella Fabiano, Clara De Simone, Paolo Gisondi, et al.
Drug Development Research|November 11, 2014
Assays and strategies for immunogenicity assessment of biological agentsFrancesca Nencini, Sara Pratesi, Giulia Petroni, et al.
Drug Development Research|November 11, 2014
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature reviewMaria Sole Chimenti, Francesca Romana Spinelli, Alessandro Giunta, et al.
Drug Development Research|November 11, 2014
Pharmacogenetics and future therapeutic scenarios: what affects the prediction of response to treatment with etanercept?Giuseppe Murdaca, Rossella Gulli, Francesca Spanò, et al.
Drug Development Research|November 11, 2014
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical responseFabio Cacciapaglia, Maria Grazia Anelli, Angela Rinaldi, et al.
Drug Development Research|November 11, 2014
Cardiovascular risk in psoriatic patients detected by heart rate variability (HRV) analysisIlaria Proietti, Gianfranco Raimondi, Nevena Skroza, et al.
Pageof 138